The Daily Caller reports the policy is slotted for sign-off at the White House, following FDA action on six peptide drugs.
Recap by typeshit. Full story at The Daily Caller on MSN.
Judge Raphael Leite Guedes in Maranhão found tirzepatide counts as a home-use drug under Law 9,656/98, even when a clinic gives the shots.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
After advisers backed adding BPC-157, TB-500, KPV and others to the 503A bulks list, pharmacists are waiting on the FDA's final decision.
Supporters of MAHA are arguing for fewer barriers to experimental peptides, framing it as personal freedom to choose what to take. Thin details in the post.
A 41-year-old and a 49-year-old died after cardiac arrest; one product appeared to come from 'research use only' seller AlphaLabs. The reports don't prove the drug caused the deaths.
TCTMD reports that two novel incretin-based agents looked highly effective in type 2 diabetes across a pair of new studies.
Loading…